Spain’s ISGlobal ranked as the third most influential global health think tank in Europe

According to the Lauder Institute’s “Global Go To Think Tank Index”, the Spanish health research center Barcelona Institute for Global Health (ISGlobal) has been ranked among the world’s ten most influential think tanks working in global health. ISGlobal has climbed up from the 16th place in 2016 to the 9th position in 2017. This ranks it the third most important global health institution in Europe and the only one not located in the United Kingdom.

Press release -ISGlobal

Spain Global health Global health R&D

Spanish think tank ISGlobal releases new report on SDG implementation

The Spanish think tank and research center Barcelona Institute for Global Health (ISGlobal) has released a new report analyzing the role of European health R&D institutions in furthering the sustainable development goals (SDGs) 2030 Agenda. Under the title “Health SDGs and Europe: the role of regional think tanks”, it suggests strengthening coordination and collaboration between research institutions and think tanks is essential to achieving the SDGs.

Press release - ISGlobal 

Swedish government provides core funding to new global health institute for 2018

The Swedish government has announced it will provide SEK1 million (US$120,000) in core funding to the Swedish Institute for Global Health Transformation, SIGHT, for the fiscal year 2018.

SIGHT is a global health institute that started in January 2017 under the auspices of the Royal Academy of Sciences. The purpose of SIGHT is to promote an interdisciplinary approach to strengthen and bridge collaborative policy work in the field of global health.

Press release – Swedish government (in Swedish) 

EDTCP calls for 2018 nominations recognizing outstanding contributions to health research

The European and Developing countries Clinical Trial Partnership (EDCTP) is seeking nominations recognizing outstanding individuals and research teams from Africa and Europe who have made significant contributions to health research in the following categories:

  • Scientific leadership;
  • Outstanding female scientist;
  • Outstanding research team;
  • The Dr. Pascoal Mocumbi Prize for scientists, policy-makers, or advocates for health and research aged 51 years and above.

In addition to scientific excellence, the awardees will have made major contributions to the EDCTP objectives of strengthening clinical research capacity in Africa, and supporting networking between developing and developed countries.

Nominations are open until February 28, 2018, 17:00 CET.

Website – EDCTP

EDCTP and GHIT announce new partnership supporting product-development research

The Global Health Innovative Technology Fund (GHIT) and the European and Developing Countries Clinical Trials Partnership (EDCTP) have announced a new partnership to support product-development research. The partners’ first action will be to co-fund a clinical study that examines the use of a new tablet formulation to treat schistosomiasis, a parasitic disease, in preschool-aged children.

According to the announcement, EDCTP and GHIT are looking forward to co-funding research of mutual interest. Both organizations share a common funding scope covering HIV/AIDS, malaria, tuberculosis, and poverty-related infectious diseases.

Website – EDCTP

European NGOs appeal for improved Council recommendations on EU research

European NGOs argue the European Council’s Committee of Permanent Representatives (COREPER I) has overlooked global health in its interim evaluation of the EU’s research program (Horizon 2020), which could impact planning around the next phase of the EU's research framework. The NGOs wrote a letter expressing their concerns on access to medicines. They called on the European Commission to increase the social impact of its medical research investments by ensuring complete transparency; improved measurement of social impact on health-related SDGs; promoting funding initiatives that focus on unmet public health needs; attaching equitable access conditions to public funding in health research; and linking open access and data requirements to publicly funded research.

Press release - Council of the EU

Letter -

EU Global health R&D

European Public Health Alliance calls for support for AMR statement

The European Public Health Alliance (EPHA) has issued, on behalf of a diverse group of public health organisations, a statement calling for eleven actions on antimicrobial resistance (AMR) that should be addressed by the European Commission and national executive agencies. These actions include, among others:

  1. Involve civil society in AMR-One Health policymaking;
  2. Support the development and implementation of National Action Plans and allocate adequate European funds to actions against AMR;
  3. Empower patients and raise public awareness.

All stakeholders interested in AMR are urged to sign the statement before January 10, 2018.

Website – EPHA

EU Global health Global health R&D

Italy pledges €4.5 million to fight polio in Afghanistan and Pakistan

The Italian government has announced a contribution of €4.5 million to eradicate polio in Afghanistan and Pakistan, with the Bill & Melinda Gates Foundation pledging to match the contribution for a total of €9 million. The funding will be used to train and support vaccinators and social mobilizers in Afghanistan, who are instrumental in generating demand for vaccination, and to ensure the delivery of vaccines. In Pakistan, the funding will be used to support vaccination campaigns in some of the most challenging areas of the country. 

Website - GPEI

EMA and EUnetHTA publish joint three-year work plan

The European Medicines Agency (EMA) and the European Network for Health Technology Assessment (EUnetHTA) have published a joint work plan for 2017-2020 to improve the efficiency and quality of medicine regulatory evaluation and health technology assessment (HTA) in the EU. The new work plan focuses on creating a joint platform for parallel consultation, information exchange at market entry, and post-authorization data generation, among other areas for collaboration.

Press release – EMA

EU Global health Global health R&D

Swedish Institute for Global Health Transformation issues 2017 award on malaria research to Andreas Mårtensson

The Swedish Institute for Global Health Transformation (SIGHT) at the Royal Academy of Sciences has awarded the 2017 SIGHT Prize for interdisciplinary malaria research to Professor Andreas Mårtensson at the Institution for Women's and Children’s Health at Uppsala University.  Mårtensson won the award for his pioneering work in malaria reduction in Zanzibar, which has led to a dramatic drop in reported cases.                                           

The SIGHT award recognizes researchers for important research in lower- and middle-income countries within global health and is financed by the Swedish foundation of the Einhorn family, 'Familjen Einhorns stiftelse', with the aim of supporting successful global- health researchers early on in their careers. 

Press release - Royal Academy of Sciences (in Swedish)